Home
HemaLogiX™
from Hemaptics™
HemaLogiX™ is an EMR integrated software system that optimizes the use of blood products, resulting in improved patient outcomes and lower costs. HemaLogiX™ increases awareness of evidence-based practice.
What is HemaLogiX™?
HemaLogiX™ is a transfusion management system built from a clinician’s lens that considers patient-specific variables in all adult settings. HemaLogiX™ aggregates current data from disparate platforms and applies evidence-based guidelines.
The platform includes an interactive dashboard with a visual representation of the percentage of transfusions that were deemed appropriate by its evidence-based algorithm.
How Does It Work?
At the heart of HemaLogiX™ is the Transfusion Appropriateness Algorithm (“TAA”), which assesses transfusion “appropriateness” by assessing over 80 patient variables (e.g., vital signs, lab values and medications) and applying evidence-based knowledge curated with input from practitioners in over 30 different specialties and sub-specialties at University Hospitals.
HemaLogiX™ also includes a data analytics platform that supports peer comparisons, departmental performance assessments, DRG filters and focused patient chart reviews.
US hospitals perform 16 million transfusions annually. Approximately 40% of these transfusions may be unnecessary.
Transfusion Appropriateness Algorithm
80+ Patient Variables
Variables include vital signs, lab values and medications.
Evidence-Based Knowledge
Includes input from 30+ Subspecialties.
Clinically Indicated Transfusions
Reducing risks to patients and costs to hospitals.
Exceptional Results
University Hospitals of Cleveland saved $2.5M in annual direct costs at its Cleveland Medical Center during the first 12 months after implementing HemaLogiX. An IRB supported study quantified a decrease in blood usage of over 10% and a 14% increase in the appropriate transfusion percentage.
Advantages of HemaLogiX™
HemaLogiX™ Has Four Distinct Advantages Over Competing Blood Management Solutions
Compelling Rationale
Assesses 80+ patient variables & applies evidence-based knowledge.
Comprehensive
Includes all adult patients and blood components.
Accurate Attribution
Assigns responsible providers at the time of order.
Real-Time Results
Utilizes current clinical data. Future release will provide guidance at the time of order.
